The validity and accuracy of the Work Productivity and Activity Impairment questionnaire -: irritable bowel syndrome version (WPAI:IBS)

被引:155
作者
Reilly, MC [1 ]
Bracco, A
Ricci, JF
Santoro, J
Stevens, T
机构
[1] Margaret Reilly Associates Inc, New York, NY USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] AGA Clin Res Associates LLC, Egg Harbor, NJ USA
关键词
D O I
10.1111/j.1365-2036.2004.02091.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Irritable bowel syndrome is a common chronic functional gastrointestinal disorder characterized by recurrent abdominal pain and discomfort associated with alterations in bowel habit. Irritable bowel syndrome affects patients' quality of life and increases productivity loss. Aim: To assess validity and accuracy of the Work Productivity and Activity Impairment questionnaire in irritable bowel syndrome as a tool for quantifying the effects of irritable bowel syndrome on productivity and daily activities. Methods: Validity and accuracy were evaluated in 135 irritable bowel syndrome patients relative to three measures of irritable bowel syndrome disease severity; a debriefing questionnaire; retrospective diary; Work Limitations Questionnaire, and an activity impairment measure (Dimensions of Daily Activities). Results: Symptom severity scores, diary scores, Work Limitations Questionnaire and Dimensions of Daily Activities were significant predictors of work productivity and activity impairment questionnaire in irritable bowel syndrome measures of work time missed, and work and activity productivity loss (P = 0.04 to < 0.0001). Impairment due to irritable bowel syndrome was estimated to be 2.9-4.3% for work time missed and 22-32% for impairment at work, the equivalent of 9.7 -14 h lost productivity per week. Activity impairment was 24-41%. Conclusions: Discriminative validity of the Work Productivity and Activity Impairment questionnaire in irritable bowel syndrome was established, making it the only validated tool for measuring the relative differences between disease severity groups and quantifying work productivity loss and activity impairment in irritable bowel syndrome patients.
引用
收藏
页码:459 / 467
页数:9
相关论文
共 46 条
[1]  
American Gastroenterological Association, 2001, BURD GASTR DIS, P1
[2]   The validity of the Work Productivity and Activity Impairment questionnaire for patients with asthma (WPAI-asthma): Results from a web-based study [J].
Andreasson, E ;
Svensson, K ;
Berggren, F .
VALUE IN HEALTH, 2003, 6 (06) :780-780
[3]   Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria [J].
Badia, X ;
Mearin, F ;
Balboa, A ;
Baró, E ;
Caldwell, E ;
Cucala, M ;
Díaz-Rubio, M ;
Fueyo, A ;
Ponce, J ;
Roset, M ;
Talley, NJ .
PHARMACOECONOMICS, 2002, 20 (11) :749-758
[4]   WHICH OUTCOME MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - CLINICAL AND QUALITY-OF-LIFE MEASURES RESPONSIVENESS TO TREATMENT IN A RANDOMIZED CONTROLLED TRIAL [J].
BUCHBINDER, R ;
BOMBARDIER, C ;
YEUNG, M ;
TUGWELL, P .
ARTHRITIS AND RHEUMATISM, 1995, 38 (11) :1568-1580
[5]   Irritable bowel syndrome [J].
Camilleri, M ;
Choi, MG .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) :3-15
[6]   Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function [J].
Cappelleri, JC ;
Siegel, RL ;
Osterloh, IH ;
Rosen, RC .
UROLOGY, 2000, 56 (03) :477-481
[7]   Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium [J].
Day, NE ;
McKeown, N ;
Wong, MY ;
Welch, A ;
Bingham, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (02) :309-317
[8]   The burden of illness of gastro-oesophageal reflux disease: impact on work productivity [J].
Dean, BB ;
Crawley, JA ;
Schmitt, CM ;
Wong, J ;
Ofman, JJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (10) :1309-1317
[9]  
Drossman DA., 2000, Rome II : the functional gastrointestinal disorders : diagnosis, pathophysiology, and treatment : a multinational consensus, V2nd
[10]   Patient self-reports in pharmacoeconomic studies - Their use and impact on study validity [J].
Evans, C ;
Crawford, B .
PHARMACOECONOMICS, 1999, 15 (03) :241-256